GeorgeCoukosMD
Obstetrics & Gynecology • Philadelphia, PAGynecologic Oncology
Professor of Obstetrics & Gynecology, University Pennsylvania
Dr. Coukos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
3 West
Philadelphia, PA 19104Phone+1 215-662-3318- Is this information wrong?
Education & Training
University of Modena Faculty of MedicineClass of 1986
Certifications & Licensure
PA State Medical License 1996 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
- Super Doctor SuperDoctors.com
Clinical Trials
- DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2012 Jan 01
- A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2007 Nov 01
- Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsTEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.Efthymia-Iliana Matthaiou, Yi Guo, Jaleh Barar, Raphael Sandaltzopoulos, Lana E Kandalaft, Chunsheng Li, George Coukos, Yadollah Omidi> ;Bioimpacts. 2022 Jan 1
- 32 citationsSensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, Blanca Navarro Rodrigo, Marta A S Perez, Florian Huber, Morgane Magnin, Tu Nguyen-Ngoc, Philippe Guillaume, Petra Ba...> ;Nature Biotechnology. 2021 Nov 15
- 15 citationsReversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.Hakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P. Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak, Hiroko Miyadera, William L. Corwin, Grant L.J. Keller, Adam...> ;Nature Communications. 2021 Nov 5
- Join now to see all
Press Mentions
AACR Names Fellows of the AACR Academy Class of 2023April 7th, 2023- AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy PresidentApril 6th, 2023
- New Immune Therapy for Advanced Melanoma Offers Hope for Hard-to-Treat DiseaseDecember 7th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
